Background The loop diuretic frusemide has been shown to inhibit the bronchoconstrictor response to exercise, inhaled allergen, distilled water, adenosine, and sodium metabisulphite. Toluene diisocyanate contracts smooth
Background The loop diuretic frusemide has been shown to inhibit the bronchoconstrictor response to exercise, inhaled allergen, distilled water, adenosine, and sodium metabisulphite. Toluene diisocyanate contracts smooth muscle by activating capsaicin sensitive nerves and causes asthma that shares many features with allergen induced asthma.
Methods The study was designed to assess the effect of two loop diuretics, bumetanide (10 and 100 PM) and frusemide (100 PM), on smooth muscle contraction induced by toluene diisocyanate (0'03-1000 PM) in guinea pig airways with and, in the case of bumetanide, without epithelium. The effect of bumetanide on the response to acetylcholine, neurokinin A, and electrical field stimulation in guinea pig bronchial smooth muscle rings was also examined.
Results Bumetanide (10 and 100 PM) had no effect on toluene diisocyanate induced contraction whether airway epithelium was present or not. Frusemide (100 pM) caused no significant inhibition of toluene diisocyanate induced contraction (mean reduction on the entire curve 25%). Bumetanide inhibited non-adrenergic, non-cholinergic contraction induced by electrical field stimulation of bronchi pretreated with atropine (1 PM) and indomethacin (5 PM) and this inhibition was inversely related to the frequency of stimulation, suggesting that bumetanide may be inhibiting transmitter release at the prejunctional level. Bumetanide and frusemide did not inhibit the responses to exogeneous acetylcholine (0 1 PM) or neurokinin A (1 nM).
Conclusions Bumetanide and frusemide in doses that are known to inhibit nonadrenergic, non-cholinergic contraction due to electrical field stimulation failed to inhibit the response to toluene diisocyanate in guinea pig airways. (Thorax 1993; 48:63-67) Bumetanide and frusemide are high ceiling diuretics and both inhibit the Na/K/Cl cotransporter in renal tubules. Bumetanide is more potent than frusemide but the two compounds have a similar effect on Na/K/Cl cotransport in various mammalian tissues.' 2 Frusemide, when administered by nebuliser but not orally, has been shown to protect asthmatic patients against non-specific and specific bronchoconstrictor stimuli.' The mechanism of action of frusemide in vivo has not been determined. Because frusemide but not bumetanide inhibits adenosine 5'-monophosphate and sodium metabisuphite induced bronchoconstriction in asthmatic persons, it was recently suggested that the protective effect of frusemide may be independent of the Na/K/ Cl cotransport.9 The effect of high ceiling diuretics such as frusemide and bumetanide could be due to inhibition of the Na/K/Cl cotransport in airway smooth muscle, thus reducing contractility,'0 or it could be due to inhibition of chloride secretion into the bronchial lumen by blocking Na/Cl cotransport on the basolateral membrane of epithelial cells." 12 Other possible mechanisms include inhibition of epithelial cell swelling and oedema induced by osmotic stimuli,'3 inhibition of mediator release from inflammatory cells,'4 15 and an effect on the responsiveness of sensory nerves."
There is evidence to suggest that loop diuretics inhibit both cholinergic and excitatory non-adrenergic, non-cholinergic neurotransmission in guinea pig airways without a direct effect on airways smooth muscle. This effect may be due to inhibition of the Na/K/Cl cotransport. As we have shown that toluene diisocyanate contracts smooth muscle by activating capsaicin sensitive sensory nerves'M20 we have studied the effects of bumetanide and frusemide on the contraction of guinea pigs airway smooth muscle in vitro induced by toluene diisocyanate. Toluene diisocyanate, a widely used industrial chemical, is a potent airway sensitiser and able to induce occupational asthma.2' We also examined the effects of bumetanide on airway smooth muscle contraction in guinea pig bronchial rings in vitro induced by acetylcholine, neurokinin A, and electrical field stimulation.
Methods

PREPARATION OF TISSUE
The experimental procedure and specific protocols were approved by the committee on animal care of the University of Padova.
Male Hartley outbred guinea pigs (Rodentia Laboratories, Torre Pallavicina, Bergamo) weighing 300-400 g were anaesthetised with pentobarbital sodium (50 mg/kg intraperitoneally). The lungs were removed rapidly and immersed in oxygenated Krebs-Henseleit solution containing 118 3 mmol/l NaCl, 4-7 mmol/l KCl, 1-2 mmol/l MgSO4, 1 2 mmol/l KH2PO4, 25-0 mmol/l NaHCO3, 2-5 mmol/l CaCl2, and 11 1 mmol/l D (+)-glucose). The main bronchi were dissected free of loose connective tissue and were prepared in two rings. The rings were mounted in glass chambers filled with 15 ml of Krebs-Henseleit solution that was maintained at 37°C and gassed with a mixture of 95% 02 and 5% Co2, which produced a pH of 7 4. The bronchial rings were connected to force displacement transducers (Grass FTO3) for continuous recording of isometric tension. The rings were allowed to equilibrate for 90 minutes while resting tension was adjusted to 5 mN. During equilibration the medium was changed every 20 minutes. Contractions were expressed as a percentage of the active tension obtained in response to acetylcholine (1 mM). Bronchial rings dissected free of epithelial and connective tissue and bronchial rings with intact epithelium were studied. The epithelium was removed by rubbing the luminal surface gently with gauze, cut into strips, and tied at one side to a suture; this was used to guide the gauze inside the bronchial rings. Removal of the epithelium was confirmed histologically. At the end of the experiment control rings and rings without epithelium were fixed in 4% formaldehyde in 0 1 M phosphate buffer at pH 7-2. After fixation, samples were dehydrated with ethanol, passed through xylene, and embedded in paraffin. Sections Toluene diisocyanate The effect of bumetanide and frusemide on the airway response to increasing concentrations of toluene diisocyanate (003-1000 mM) was assessed. After an equilibration period a baseline response to acetylcholine was obtained. The rings were then rinsed. Parallel experiments were carried out on paired bronchial rings from the same animal; bumetanide (10 jiM or 100 MuM, contact time 30 minutes) or frusemide (100 uM, contact time 30 minutes) was added to one of the two bronchial rings of each animal and nothing was added to the second ring. The response to increasing concentrations of toluene diisocyanate was then measured in both rings. Each successive concentration of toluene diisocyanate was added only after the previous response had reached a constant value. The effect of bumetanide was studied on rings with and without epithelium; the effect offrusemide was studied on rings with epithelium.
Neurokinin A, acetylcholine, and electrical field stimulation
The effect of bumetanide (10 jpM) on the responses to neurokinin A, acetylcholine (0-1 jIM), and electrical field stimulation was also examined. In these experiments atropine (1 jMM) was added to antagonise the cholinergic component of the response to electrical field stimulation and indomethacin (5 ,uM) Bumetan- ide (10 and 100 MM) did not alter the toluene diisocyanate induced contractions (fig 1) .
Toluene diisocyanate also caused contraction in bronchial rings without epithelium, and this did not differ significantly between control rings and rings pretreated with bumetanide (10 and 100 uM; fig 2) . Histological analysis confirmed that 94-1 (4 6)% of the epithelium had been removed.
Frusemide (100 MM) did not alter toluene diisocyanate induced contraction significantly (fig 3) . At a concentration of300 pM oftoluene diisocyanate there was a 39% reduction in rings pretreated with frusemide (95% confidence interval (95% CI) 78%-14% of response to 1 mM acetylcholine). The mean values found in control rings and in frusemide treated rings were 64-5 (14-3)% (95% CI 97%-32% of the response to 1 mM acetylcholine) and 39-1 (6 7)% (95% CI 54%-24% of the response to 1 mM acetylcholine) respectively. The table gives the results for both drugs. without epithelium failed to inhibit contraction induced by exogenous histamine, potassium chloride, or hyperosmolar saline, and was also without effect on hypertonic saline induced contraction in bovine and human airways with epithelium intact. The conclusions from this study, by Knox and Ajao,22 were that inhibition of Na/K/Cl cotransport does not alter airway smooth muscle contractility and that the protective effect of frusemide on bronchoconstrictor stimuli in vivo is unlikely to be due to a direct effect on airway smooth muscle. We found a similar lack of response with bumetanide on contractions induced by acetylcholine and neurokinin A on bronchial tissue with intact epithelium, so this would explain the lack of effect of loop diuretics in preparations with intact epithelium is not confined to one stimulus. Inhaled frusemide has a protective effect on a wide range of bronchoconstrictor stimuli in vivo. It also inhibits cough induced by inhalation of solutions with low chloride content in humans but not that induced by capsaicin.23
The mechanism of action of frusemide on these different stimuli is not understood. Our results and the findings of previous studies suggest that, in human, bovine, and guinea pig airways at least, loop diuretics at concentrations that inhibit Na/K/Cl cotransport do not alter airway smooth muscle contractility.
Bumetanide inhibited contraction induced by electrical field stimulation. Electrical field stimulation in isolated bronchi of guinea pigs produces a reproducible constrictor response that is thought to be due to antidromic activation of capsaicin sensitive nerves, the response being largely mediated by endogenous tachykinin like peptides.2"27 Previous work has shown that bumetanide and frusemide inhibit both cholinergic and non-cholinergic excitatory nerves in guinea pig airways in vitro"7 and one possible mechanism of action of these diuretics could be inhibition of the Na/K/Cl cotransport protein in airway nerves.
In 
